The name is absent



Abstract

Bayesian Semiparametric and Flexible Models for
Analyzing Biomedical Data

by

Luis G. Leon Novelo

In this thesis I develop novel Bayesian inference approaches for some typical data
analysis problems as they arise with biomedical data. The common theme is the use of
flexible and semi-parametric Bayesian models and computation intensive simulation-
based implementations. In chapter 2, I propose a new approach for inference with
multivariate ordinal data. The application concerns the assessment of toxicities in
a phase III clinical trial. The method generalizes the ordinal probit model. It is
based on flexible mixture models. In chapter 3, I develop a semi-parametric Bayesian
approach for bio-panning phage display experiments. The nature of the model is a
mixed effects model for repeated count measurements of peptides. I develop a non-
parametric Bayesian random effects distribution and show how it can be used for the
desired inference about organ-specific binding. In chapter 4, I introduce a variation
of the product partition model with a non-exchangeable prior structure. The model
is applied to estimate the success rates in a phase II clinical of patients with sarcoma.
Each patient presents one subtype of the disease and subtypes are grouped by good,
intermediate and poor prognosis. The prior model respects the varying prognosis
across disease subtypes. Two subtypes with equal prognoses are more likely a priori
to have similar success rates than two subtypes with different prognoses.



More intriguing information

1. SOME ISSUES IN LAND TENURE, OWNERSHIP AND CONTROL IN DISPERSED VS. CONCENTRATED AGRICULTURE
2. The name is absent
3. Howard Gardner : the myth of Multiple Intelligences
4. Long-Term Capital Movements
5. The name is absent
6. Commuting in multinodal urban systems: An empirical comparison of three alternative models
7. A Study of Prospective Ophthalmology Residents’ Career Perceptions
8. The name is absent
9. The name is absent
10. Explaining Growth in Dutch Agriculture: Prices, Public R&D, and Technological Change